Not really. That 5.5 million or so will be burnt through very quickly with a multi-country trial and possibly looking to commence a separate trial in the US. Spend was at roughly 2m in the previous quarter and it won't be lower than that going forward. 2-3 quarters left. Im sure they'll start dangling the 'partnerships' carrot soon like every other Aussie biotech, and it'll likely amount to nothing like every other biotech! Some mid-way efficacy and a raise at slightly higher prices I assume is what they're trying to hang on for.. Unsure if that'll be feasible.
- Forums
- ASX - By Stock
- ATX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.001(1.06%) |
Mkt cap ! $26.10M |
Open | High | Low | Value | Volume |
9.5¢ | 10.0¢ | 9.4¢ | $22.98K | 240.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 146804 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 52046 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 146804 | 0.095 |
1 | 95561 | 0.094 |
1 | 50000 | 0.093 |
1 | 10869 | 0.092 |
3 | 400000 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 149919 | 2 |
0.110 | 325 | 1 |
0.130 | 2243 | 1 |
0.140 | 173297 | 4 |
0.145 | 120000 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |